Trattamento non farmacologico eco-guidato nei pazienti con cardiomiopatia ipertrofica ostruttiva

Translated title of the contribution: Non-pharmacological treatment of hypertrophic obstructive cardiomyopathy guided by echocardiography

Giovanni La Canna, Matteo Montorfano, Eleonora Ficarra, Iassen Michev, Elvia Capritti, Antonio Grimaldi, Francesco De Cobelli, Alessandro Verzini, Antonio Colombo, Ottavio Alfieri

Research output: Contribution to journalArticlepeer-review

Abstract

As a relevant cause of symptoms and adverse clinical prognosis, left ventricular obstruction should be regarded as an important therapeutic target in patients with hypertrophic obstructive cardiomyopathy. The surgical approach (including septal myectomy or mitral valve surgery) and percutaneous transluminal septal myocardial ablation offer a non-pharmacological option for the treatment of symptomatic left ventricular obstruction and symptoms unresponsive to medical treatment. The surgical approach is established as an effective strategy for relieving symptoms from dynamic obstruction. Percutaneous septal ablation, on the other hand, has only recently been introduced into clinical practice and, despite its efficacy as an obstructive abolisher, little is known about the prognostic long-term impact of procedural-induced myocardial damage. Due to its accuracy and diagnostic versatility, including intraprocedural use, Doppler echocardiography provides essential information for the planning and monitoring of non-pharmacological therapy in patients with hypertrophic obstructive cardiomyopathy.

Translated title of the contributionNon-pharmacological treatment of hypertrophic obstructive cardiomyopathy guided by echocardiography
Original languageItalian
Pages (from-to)192-205
Number of pages14
JournalGiornale Italiano di Cardiologia
Volume7
Issue number3
Publication statusPublished - Mar 2006

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Non-pharmacological treatment of hypertrophic obstructive cardiomyopathy guided by echocardiography'. Together they form a unique fingerprint.

Cite this